News|Articles|December 9, 2024
Characterization and Release Testing for AAV Therapies
Author(s)Charles River
Characterization and Release Testing for AAV Therapies – the Importance of Empty/Partial/Full Capsid Analysis and its Impact on Potency
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Industry Experts Probe CNPV Impacts: Part II
2
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
3
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
4
How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control
5
